AstraZeneca India to review financial results at board meeting on November 5, 2026 Back

<p>AstraZeneca Pharma India Limited will hold a meeting of its Board of Directors on Thursday, November 5, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, the company said in a filing. The trading window for designated persons will remain closed from September 16, 2026, to November 7, 2026, in accordance with the company’s insider trading policy.</p>